Characterization of the antinociceptive effects of oxycodone in diabetic mice

European Journal of Pharmacology

Volumn 535, Issue 1-3, 2006, Pages 145-151

  Nozaki, Chihiro ^a   Saitoh, Akiyoshi ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Opioid receptors; Antinociception; Diabetes; Hyperalgesia; Oxycodone

Indexed keywords

BETA FUNALTREXAMINE; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE; NOR BINALTORPHIMINE; OXYCODONE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; HYPERALGESIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; DIABETES MELLITUS, EXPERIMENTAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED ICR; NALTREXONE; NARCOTIC ANTAGONISTS; OXYCODONE; PAIN; PAIN MEASUREMENT; STREPTOZOCIN;

EID: 33645386533     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.002     Document Type: Article

References (33)

1. W.T. Beaver, S.L. Wallenstein, A. Rogers, and R.W. Houde Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine J. Pharmacol. Exp. Ther. 207 1978 92 100
2. A.J. Boulton, F.A. Gries, and J.A. Jervell Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy Diabet. Med. 15 1998 508 514
3. M.J. Brown, and A.K. Asbury Diabetic neuropathy Ann. Neurol. 15 1984 2 12
4. S.R. Chen, and H.L. Pan Antinociceptive effect of morphine, but not μ opioid receptor number, is attenuated in the spinal cord of diabetic rats Anesthesiology 99 2003 1409 1414
5. Z.R. Chen, R.J. Irvine, A. Somogyi, and F. Bochner Mu receptor binding of some commonly used opioids and their metabolites Life Sci. 48 1991 2165 2171
6. S.R. Chen, K.L. Sweigart, J.M. Lakoski, and H.L. Pan Functional μ opioid receptors are reduced in the spinal cord dorsal horn in rats Anesthesiology 97 2002 1602 1608
7. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J. Pharmacol. Exp. Ther. 72 1941 74 79
8. T. Endoh, H. Matsuura, C. Tanaka, and H. Nagase Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo Arch. Int. Pharmacodyn. Ther. 316 1992 30 42
9. M.J. Haley, and W.G. McCormik Pharmacological effects produced by intracerebral injection of drug in the conscious mice Br. J. Pharmacol. 12 1957 12 15
10. J.L.K. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur. J. Pharmacol. 67 1980 313 316
11. E. Kalso, A. Vainio, M.J. Mattila, P.H. Rosenburg, and T. Seppala Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays Pharmacol. Toxicol. 67 1990 322 328
12. J. Kamei, Y. Ohhashi, T. Aoki, N. Kawashima, and Y. Kasuya Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists Brain Res. 571 1992 199 203
13. J. Kamei, N. Kawashima, and Y. Kasuya Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice Brain Res. 576 1992 139 142
14. 2- opioid receptors Neurosci. Lett. 165 1994 141 143
15. 2-opioid receptors Life Sci. 55 1994 121 126
16. J. Kamei, Y. Iwamoto, M. Misawa, H. Nagase, and Y. Kasuya Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice Res. Commun. Chem. Pathol. Pharmacol. 84 1994 105 110
17. J. Kamei, A. Saitoh, M. Ohsawa, T. Suzuki, M. Misawa, H. Nagase, and Y. Kasuya Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice Eur. J. Pharmacol. 276 1995 131 135
18. J. Kamei, M. Ohsawa, A. Saitoh, Y. Iwamoto, T. Suzuki, M. Misawa, H. Nagase, and Y. Kasuya Modification of μ-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes J. Pharmacol. Exp. Ther. 274 1995 700 706
19. 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice Eur. J. Pharmacol. 322 1997 27 30
20. J. Kamei, K. Zushida, M. Ohsawa, and H. Nagase The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice Eur. J. Pharmacol. 391 2000 91 96
21. J. Kamei, K. Zushida, K. Morita, M. Sasaki, and S. Tanaka Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice Eur. J. Pharmacol. 422 2001 83 86
22. C.K. Nielsen, F.B. Ross, and M.T. Smith Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat J. Pharmacol. Exp. Ther. 295 2000 91 99
23. C. Nozaki, A. Saitoh, N. Tamura, and J. Kamei Antinociceptive effect of oxycodone in diabetic mice Eur. J. Pharmacol. 524 2005 75 79
24. 5] enkephalin-induced antinociception in diabetic mice Eur. J. Pharmacol. 339 1997 27 31
25. M. Ohsawa, and J. Kamei Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice Brain Res. 833 1999 278 281
26. M. Ohsawa, H. Mizoguchi, M. Narita, J. Kamei, H. Nagase, and L.F. Tseng Effects of a μ-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice Eur. J. Pharmacol. 401 2000 55 58
27. F.B. Ross, and M.T. Smith The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated Pain 73 1997 151 157
28. A. Saitoh, Y. Yoshikawa, K. Onodera, and J. Kamei Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats Psychopharmacology 182 2005 327 334
29. G.S. Simon, and W.L. Dewey Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine J. Pharmacol. Exp. Ther. 218 1981 318 323
30. Y. Suzuki, K. Goto, K. Shiizaki, Y. Omiya, A. Ishige, Y. Komatsu, and J. Kamei Antinociceptive effect of U-50488H, a κ-opioid agonist, in streptozotocin-induced diabetic mice J. Pharm. Pharmacol. 53 2001 521 526
31. M. Tandon, R.K. Srivastava, R.K. Nagpal, P. Khosla, and J. Singh Differential modulation of nociceptive responses to μ and κ opioid receptor directed drugs by blood glucose in experimentally induced diabetes rats Indian J. Exp. Biol. 38 2000 242 248
32. T.D. Wolinsky, G.C. Abrahamsen, and K.D. Carr Diabetes alters μ and κ opioid binding in rat brain regions: comparison with effects of food restriction Brain Res. 738 1996 167 171
33. J.M. Wright Review of the symptomatic treatment of diabetic neuropathy Pharmacotherapy 14 1994 689 697